HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High dose frusemide in acute renal failure: a controlled trial.

Abstract
Fifty-eight patients in established acute renal failure following trauma or surgery were allocated in a prospective and random fashion to two different diuretic regimes. In the control group, 1 g frusemide was given as a single injection over four hours. In the test group, frusemide was then continued either intravenously or orally in a dose of 3 g/24 hr until a urine output of 200 ml/hr was sustained or until the plasma creatinine fell below 300 mumoles/l. Oliguria was reversed or prevented in 24 of 28 patients given sustained frusemide, but in only 2 patients given a single injection. However, the number of dialyses and duration of renal failure and mortality were not different in the two groups. The serious complication of deafness occurred in two patients and in one of them this was permanent.
AuthorsC B Brown, C S Ogg, J S Cameron
JournalClinical nephrology (Clin Nephrol) Vol. 15 Issue 2 Pg. 90-6 (Feb 1981) ISSN: 0301-0430 [Print] Germany
PMID7011622 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Furosemide
Topics
  • Acute Kidney Injury (drug therapy)
  • Administration, Oral
  • Clinical Trials as Topic
  • Female
  • Furosemide (administration & dosage)
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: